USPH Stock Analysis: Buy, Sell, or Hold?
USPH - US Physical Therapy Inc
$78.21
0.21 (0.27%)
â˛
5d:
-3.73%
30d:
+7.18%
90d:
+24.44%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 05, 2026
0d
Get Alerted When USPH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: USPH is fairly priced but lacks strong directional signals. At -0.2% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: USPH is fairly priced but lacks strong directional signals. At -0.2% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$129.00
Based on 10.5% avg growth
INTRINSIC VALUE TODAY
$80.10
2.4% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 23.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: USPH is currently trading at $78.21, which is considered fair relative to its 30-day fair value range of $74.14 to $80.64. The stock's valuation (Forward PE: 23.1) is in line with its historical norms (23.3). Remarkably, the market is currently pricing in an annual earnings decline of 0.2% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, USPH is in a uptrend. The price is currently testing key support at $77.07. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 53/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $95.00 (+21.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, USPH is in a uptrend. The price is currently testing key support at $77.07. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 53/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $95.00 (+21.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$74.14 -
$80.64
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.4%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (53/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 21.5% below Wall St target ($95.00)
- WARNING: Composite score 50/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$74.14 -
$80.64
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$77.07
Resistance Level
$83.43
Current Trend
Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
23.12
Wall Street Target
$95.00
(+21.5%)
Revenue Growth (YoY)
8.5%
Earnings Growth (YoY)
-56.5%
Profit Margin
4.0%
Valuation Discount vs History
-0.2% cheaper
PE vs Historical
23.1 vs 23.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.2%
(market-implied from PE analysis)
1-Year Target
$78.05
(0%)
2-Year Target
$77.90
(0%)
3-Year Target
$77.74
(-1%)
3-Yr Target (if PE normalizes)
(PE: 23â23)
$78.34
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 23.1, Growth: 16.9%)
$124.94
(+60%)
Base:
(SPY PE: 20.1, Growth: 16.9%)
$108.45
(+39%)
Bear:
(PE: 17.1, Growth: 16.9%)
$92.18
(+18%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (29x PE), but valuation improves significantly next year (23x PE) as earnings recover.
Forward PE: 28.82 | Forward EPS (Implied): $2.71
Bull Case
$94.44
(+21%)
Analyst growth 15.0%, PE expands to 30.3
Base Case
$78.21
(0%)
Market implied 0.0%, PE stable at 28.8
Bear Case
$59.83
(-24%)
Severe decline -15.0%, PE contracts to 25.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 23.1 to 23.3
Stabilization Target:
$78.81
(+0.8%)
PE Expansion Potential:
+0.8%
Share & Embed Analysis
Last updated: August 22, 2026 6:27 PM ET
Data refreshes hourly during market hours. Next update: 7:27 PM
Data refreshes hourly during market hours. Next update: 7:27 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is USPH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Graham D Reeve
SELL
662 shares
2026-03-11
Richard Binstein
SELL
3000 shares
2026-03-06
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare CorporaâĻ |
STRONG BUY
22 analysts |
$282 | 37 SELL |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$455 | 44 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 47 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$148 | 42 HOLD |
|
ADUS
Addus HomeCare CorporatiâĻ |
STRONG BUY
11 analysts |
$135 | 54 HOLD |
